{"product_id":"wc-0efe51bcb5f34c14-51152","title":"A4M Peptide Therapy Certification – On-Demand – 2026 – Module I: Regenerative \u0026 Reparative Peptides","description":"\u003cdiv\u003e\r\n\u003ch1 data-pm-slice=\"1 1 []\"\u003eAmerican Academy of Anti-Aging Medicine Peptide Therapy Certification – Module I 2026\u003c\/h1\u003e\r\n\u003ch2\u003eA4M Peptide Therapy Certification Module I 2026 | Regenerative \u0026amp; Reparative Peptides, Metabolic Health, Immune Modulation, Tissue Repair, Longevity, Hormone Signaling \u0026amp; Clinical Peptide Science\u003c\/h2\u003e\r\nThe \u003cstrong\u003eA4M Peptide Therapy Certification 2026 – Module I: Regenerative \u0026amp; Reparative Peptides\u003c\/strong\u003e is an advanced on-demand professional education program developed by the \u003cstrong\u003eAmerican Academy of Anti-Aging Medicine (A4M)\u003c\/strong\u003e, focusing on peptide science, regenerative medicine, metabolic health, immune regulation, tissue repair, hormone signaling, cellular aging, and emerging therapeutic research.\r\n\r\nAs the foundational module of A4M's two-part Peptide Therapy Certification program, Module I combines scientific principles with practical clinical considerations involving peptide-related interventions, pharmaceutical quality, regulatory status, individualized assessment, and patient safety.\r\n\r\nFeaturing physicians, pharmacists, researchers, and experienced clinicians, the curriculum explores the biological mechanisms and available evidence surrounding peptides involved in metabolic regulation, connective tissue biology, growth hormone signaling, immune pathways, gastrointestinal function, cellular communication, and neuroinflammation.\r\n\r\nThe \u003cstrong\u003eA4M Peptide Therapy Certification Module I 2026\u003c\/strong\u003e also provides extensive education on FDA regulatory considerations, state-level regulations, pharmaceutical manufacturing, sterile product quality control, clinical evidence assessment, and responsible integration of emerging therapies into professional medical practice.\r\n\r\nImportant peptide compounds and related therapeutic categories discussed include \u003cstrong\u003eBPC-157, thymosin beta-4, KPV, RGN-259, VIP, Selank, CJC-1295, ipamorelin, sermorelin, tesamorelin, MOTS-c, thymosin alpha-1, GLP-1 receptor agonists, and other research compounds\u003c\/strong\u003e.\r\n\r\nThe course emphasizes that peptide-based medications differ significantly in clinical evidence, approval status, manufacturing quality, safety, and appropriate medical indications.\r\n\r\nThrough 18 scheduled educational sessions, the program introduces contemporary peptide medicine while addressing the scientific limitations and clinical responsibilities associated with this evolving field.\r\n\u003ch2\u003eCourse Details\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e American Academy of Anti-Aging Medicine Peptide Therapy Certification – Module I 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eModule Title:\u003c\/strong\u003e Regenerative \u0026amp; Reparative Peptides\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eProvider:\u003c\/strong\u003e American Academy of Anti-Aging Medicine (A4M)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAssociated Organization:\u003c\/strong\u003e International Peptide Society\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEdition:\u003c\/strong\u003e 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eModule:\u003c\/strong\u003e I – Regenerative \u0026amp; Reparative Peptides\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOriginal Format:\u003c\/strong\u003e On-Demand Professional Education\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eMedicalAmboss Package:\u003c\/strong\u003e Videos + Subtitles + PDFs\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eScheduled Educational Sessions:\u003c\/strong\u003e 18\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePublished Instructional Schedule:\u003c\/strong\u003e Approximately 21.5 Hours, including a non-CME presentation\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePrimary Specialty:\u003c\/strong\u003e Peptide Medicine \/ Regenerative Medicine\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAdditional Focus:\u003c\/strong\u003e Internal Medicine, Endocrinology, Metabolic Health, Longevity, Clinical Pharmacology, Immunology and Tissue Repair\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eTarget Audience:\u003c\/strong\u003e Licensed Healthcare Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Methods:\u003c\/strong\u003e Expert Lectures, Regulatory Reviews, Scientific Presentations and Case-Based Discussions\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Certification Structure:\u003c\/strong\u003e Two Modules\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe published instructional duration describes the original educational schedule and is not an independently verified runtime of the files delivered through MedicalAmboss.\r\n\u003ch2\u003ePackage Includes\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\u003cstrong\u003eModule I Video Lectures\u003c\/strong\u003e\u003c\/li\u003e\r\n \t\u003cli\u003e\u003cstrong\u003eSubtitle Files\u003c\/strong\u003e\u003c\/li\u003e\r\n \t\u003cli\u003e\u003cstrong\u003eCourse PDFs\u003c\/strong\u003e\u003c\/li\u003e\r\n \t\u003cli\u003eOn-Demand Digital Educational Materials\u003c\/li\u003e\r\n \t\u003cli\u003eDownloadable Study Content\u003c\/li\u003e\r\n \t\u003cli\u003eOffline Study Access\u003c\/li\u003e\r\n \t\u003cli\u003eDigital Delivery\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe package description is based on the supplied product information. Exact numbers of videos, subtitle files, and PDFs should be checked against the delivered files.\r\n\u003ch2\u003eTarget Audience\u003c\/h2\u003e\r\nThe program is intended for licensed healthcare practitioners interested in peptide science, regenerative medicine, metabolic regulation, longevity research, and responsible assessment of emerging therapies.\r\n\r\nThe target audience includes:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eGeneral Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eEndocrinologists\u003c\/li\u003e\r\n \t\u003cli\u003eRegenerative Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Medicine Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrative Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eSports Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eAesthetic Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologists\u003c\/li\u003e\r\n \t\u003cli\u003ePharmacists\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Pharmacologists\u003c\/li\u003e\r\n \t\u003cli\u003eOsteopathic Physicians\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician Assistants\u003c\/li\u003e\r\n \t\u003cli\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eRegistered Nurses\u003c\/li\u003e\r\n \t\u003cli\u003eOther Eligible Licensed Healthcare Professionals\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe program is particularly relevant to clinicians seeking a structured understanding of peptide mechanisms, clinical evidence, regulatory requirements, product quality, and individualized patient assessment.\r\n\u003ch2\u003eProgram Overview\u003c\/h2\u003e\r\nPeptides are amino acid-based molecules involved in diverse biological processes, including cell signaling, endocrine regulation, metabolic activity, immune function, and physiological homeostasis.\r\n\r\nCertain peptide-based medications have established therapeutic applications supported by regulatory approval and clinical studies.\r\n\r\nOther peptides discussed in regenerative, longevity, or performance medicine remain investigational, and their clinical effectiveness or long-term safety may not be established.\r\n\r\nThe \u003cstrong\u003eA4M Peptide Therapy Certification Module I 2026\u003c\/strong\u003e explores this expanding field through a curriculum that combines scientific, clinical, pharmaceutical, and regulatory perspectives.\r\n\r\nThe program covers:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePeptide Medicine Fundamentals\u003c\/li\u003e\r\n \t\u003cli\u003eRegenerative and Reparative Peptides\u003c\/li\u003e\r\n \t\u003cli\u003eMetaflammation\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Signaling\u003c\/li\u003e\r\n \t\u003cli\u003ePharmaceutical Quality Assurance\u003c\/li\u003e\r\n \t\u003cli\u003eFDA Regulatory Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eState-Level Regulations\u003c\/li\u003e\r\n \t\u003cli\u003eSterile Manufacturing\u003c\/li\u003e\r\n \t\u003cli\u003eCompounding Considerations\u003c\/li\u003e\r\n \t\u003cli\u003ePersonalized Clinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eNutrition and Lifestyle Integration\u003c\/li\u003e\r\n \t\u003cli\u003eSelective Androgen Receptor Modulators\u003c\/li\u003e\r\n \t\u003cli\u003eBody Composition\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Health\u003c\/li\u003e\r\n \t\u003cli\u003eGlucose and Insulin Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eGrowth Hormone Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eImmune Modulation\u003c\/li\u003e\r\n \t\u003cli\u003eGut Biology\u003c\/li\u003e\r\n \t\u003cli\u003eGastrointestinal Barrier Function\u003c\/li\u003e\r\n \t\u003cli\u003eLiposomal Oral Peptides\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide Bioregulators\u003c\/li\u003e\r\n \t\u003cli\u003eConnective Tissue Repair\u003c\/li\u003e\r\n \t\u003cli\u003eOrgan Repair Research\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Senescence\u003c\/li\u003e\r\n \t\u003cli\u003eDNA Damage\u003c\/li\u003e\r\n \t\u003cli\u003eTelomere Biology\u003c\/li\u003e\r\n \t\u003cli\u003eHormone Receptor Modulation\u003c\/li\u003e\r\n \t\u003cli\u003eNeuroinflammation\u003c\/li\u003e\r\n \t\u003cli\u003eAutoimmune Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Case Discussions\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe program emphasizes evaluating potential clinical applications within the context of available scientific evidence and applicable regulations.\r\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\r\nAfter completing the educational program, participants should be better able to:\r\n\u003col start=\"1\" data-spread=\"true\"\u003e\r\n \t\u003cli\u003eExplain the fundamentals of peptide science and its relationship to metabolic signaling, immune regulation, endocrine function, and tissue biology.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize the regulatory distinctions between FDA-approved peptide medications, investigational compounds, and compounded preparations.\u003c\/li\u003e\r\n \t\u003cli\u003eDiscuss pharmaceutical quality assurance, sterile manufacturing, product integrity, and related patient safety concerns.\u003c\/li\u003e\r\n \t\u003cli\u003eApply individualized clinical assessment principles when evaluating proposed peptide-related treatment approaches.\u003c\/li\u003e\r\n \t\u003cli\u003eReview the role of nutrition, exercise, sleep, and lifestyle factors in metabolic and regenerative medicine.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate contemporary research involving body composition, insulin regulation, and peptide-related metabolic pathways.\u003c\/li\u003e\r\n \t\u003cli\u003eDescribe the relationship between gut barrier biology, inflammation, and immune modulation.\u003c\/li\u003e\r\n \t\u003cli\u003eCritically assess scientific evidence involving regenerative and reparative peptides.\u003c\/li\u003e\r\n \t\u003cli\u003eReview the physiological pathways associated with growth hormone signaling and related compounds.\u003c\/li\u003e\r\n \t\u003cli\u003eExplain fundamental concepts involving cellular senescence, DNA damage, telomere biology, and aging research.\u003c\/li\u003e\r\n \t\u003cli\u003eReview peptide-related research involving neuroinflammation, autoimmune mechanisms, and central nervous system signaling.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrate principles of evidence appraisal, clinical safety, regulatory compliance, and patient communication into professional decision-making.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eOfficial Module I Curriculum\u003c\/h1\u003e\r\n\u003ch2\u003eSession I – Peptide Science and Metabolic Signaling\u003c\/h2\u003e\r\n\u003ch3\u003e1. Peptides Overview: Controlling Metaflammation, Metabolic Signaling \u0026amp; Clinical Value\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis introductory presentation examines peptide-related biological signaling and its potential relevance to metabolic and inflammatory pathways.\r\n\r\nMetaflammation refers to chronic, low-grade inflammatory processes associated with metabolic dysfunction.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePeptide Biology\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eMetaflammation\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Communication\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Pathways\u003c\/li\u003e\r\n \t\u003cli\u003eEnergy Metabolism\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Research\u003c\/li\u003e\r\n \t\u003cli\u003eStrength of Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eTranslational Medicine\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Assessment\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session establishes a scientific foundation for understanding subsequent discussions of peptide medicine.\r\n\u003ch2\u003eSession II – FDA Regulations and Pharmaceutical Quality\u003c\/h2\u003e\r\n\u003ch3\u003e2. FDA, Quality Assurance, and State-to-State Status: Where Are We Now and Where Is It Going?\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Tyler Chamberlain, PharmD, FAPC\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1.5 Hours\r\n\r\nThis presentation reviews the regulatory landscape affecting peptide products and related pharmaceutical preparations.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFDA Regulatory Status\u003c\/li\u003e\r\n \t\u003cli\u003eApproved Prescription Medications\u003c\/li\u003e\r\n \t\u003cli\u003eInvestigational Compounds\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Compounding\u003c\/li\u003e\r\n \t\u003cli\u003eState-Level Regulations\u003c\/li\u003e\r\n \t\u003cli\u003eQuality Assurance\u003c\/li\u003e\r\n \t\u003cli\u003eProduct Availability\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Documentation\u003c\/li\u003e\r\n \t\u003cli\u003eProfessional Responsibilities\u003c\/li\u003e\r\n \t\u003cli\u003eRegulatory Changes\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes the importance of understanding what is legally permitted and supported by evidence before considering a specific clinical intervention.\r\n\u003ch3\u003e3. Manufacturing of Sterile Product Quality Control: Understanding the \"For Human Use Difference\"\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Anthony J. Campbell, PharmD, BCSCP\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis session examines pharmaceutical manufacturing and quality control principles relevant to sterile preparations intended for human use.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSterile Product Manufacturing\u003c\/li\u003e\r\n \t\u003cli\u003ePharmaceutical Quality\u003c\/li\u003e\r\n \t\u003cli\u003eProduct Purity\u003c\/li\u003e\r\n \t\u003cli\u003eSterility Assurance\u003c\/li\u003e\r\n \t\u003cli\u003eContamination Prevention\u003c\/li\u003e\r\n \t\u003cli\u003eManufacturing Standards\u003c\/li\u003e\r\n \t\u003cli\u003eQuality Testing\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Safety\u003c\/li\u003e\r\n \t\u003cli\u003eProduct Integrity\u003c\/li\u003e\r\n \t\u003cli\u003eRegulatory Compliance\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e4. Manufacturing of Sterile Product Quality Control – Continued\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Anthony J. Campbell, PharmD, BCSCP\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThe second presentation expands upon sterile pharmaceutical manufacturing and associated quality considerations.\r\n\r\nImportant areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSterile Compounding\u003c\/li\u003e\r\n \t\u003cli\u003eQuality Assurance\u003c\/li\u003e\r\n \t\u003cli\u003ePharmaceutical Manufacturing Controls\u003c\/li\u003e\r\n \t\u003cli\u003eProduct Handling\u003c\/li\u003e\r\n \t\u003cli\u003eStorage Considerations\u003c\/li\u003e\r\n \t\u003cli\u003ePotency and Purity\u003c\/li\u003e\r\n \t\u003cli\u003eContamination Risks\u003c\/li\u003e\r\n \t\u003cli\u003eDocumentation\u003c\/li\u003e\r\n \t\u003cli\u003eQuality Systems\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Safety\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese sessions highlight the importance of pharmaceutical quality when evaluating products intended for human administration.\r\n\u003ch2\u003eSession III – Personalized Clinical Assessment\u003c\/h2\u003e\r\n\u003ch3\u003e5. Personalized Peptide Protocols: Integrating Nutrition, Exercise \u0026amp; Lifestyle for Optimal Outcomes\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Stephanie Mazurek, PharmD\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 30 Minutes\r\n\r\nThis session examines the relationship between proposed peptide-related interventions and broader patient management.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eIndividualized Patient Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eNutrition\u003c\/li\u003e\r\n \t\u003cli\u003eExercise\u003c\/li\u003e\r\n \t\u003cli\u003eSleep\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle\u003c\/li\u003e\r\n \t\u003cli\u003eMedical History\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Review\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Risk\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Goals\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eFollow-Up Planning\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes evaluating the full clinical context rather than focusing exclusively on individual compounds.\r\n\u003ch3\u003e6. Integrating Peptides into Clinical Practice\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Erika Schwartz, MD\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis presentation reviews practical and professional considerations surrounding the discussion and evaluation of peptide-related therapies in clinical settings.\r\n\r\nRelevant areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eClinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eProfessional Scope of Practice\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Eligibility\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence Appraisal\u003c\/li\u003e\r\n \t\u003cli\u003eSafety Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eRegulatory Status\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Counseling\u003c\/li\u003e\r\n \t\u003cli\u003eDocumentation\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Workflow\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Decision-Making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e7. Global Lifestyle Considerations in Peptide Medicine\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1.5 Hours\r\n\r\nThis session reviews the broader physiological and lifestyle context relevant to metabolic health and regenerative medicine.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNutritional Assessment\u003c\/li\u003e\r\n \t\u003cli\u003ePhysical Activity\u003c\/li\u003e\r\n \t\u003cli\u003eSleep\u003c\/li\u003e\r\n \t\u003cli\u003eStress\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eInflammation\u003c\/li\u003e\r\n \t\u003cli\u003eBody Composition\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eIndividual Patient Variability\u003c\/li\u003e\r\n \t\u003cli\u003eLong-Term Health\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eSession IV – Hormone Signaling and Body Composition\u003c\/h2\u003e\r\n\u003ch3\u003e8. SARMs – What Are They? The Science and Controversy\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis presentation reviews selective androgen receptor modulators and related scientific controversies.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSelective Androgen Receptor Modulators\u003c\/li\u003e\r\n \t\u003cli\u003eAndrogen Receptor Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eMuscle Biology\u003c\/li\u003e\r\n \t\u003cli\u003eBody Composition\u003c\/li\u003e\r\n \t\u003cli\u003eExperimental Therapeutic Research\u003c\/li\u003e\r\n \t\u003cli\u003ePotential Adverse Effects\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Disruption\u003c\/li\u003e\r\n \t\u003cli\u003eRegulatory Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence Limitations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eSARMs are not peptides\u003c\/strong\u003e, and their inclusion reflects their relationship to discussions of body composition and hormone signaling.\r\n\u003ch3\u003e9. Body Composition and Metabolism\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Gordon Crozier, DO\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 2.5 Hours\r\n\r\nThis presentation examines metabolic health and physiological factors relevant to body composition.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBody Composition Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eAdipose Tissue\u003c\/li\u003e\r\n \t\u003cli\u003eSkeletal Muscle\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Health\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin Sensitivity\u003c\/li\u003e\r\n \t\u003cli\u003eEnergy Balance\u003c\/li\u003e\r\n \t\u003cli\u003eHormone Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Clinical Assessment\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session provides context for understanding metabolic pathways and proposed peptide-related applications.\r\n\u003ch2\u003eSession V – Immune Modulation and Gastrointestinal Health\u003c\/h2\u003e\r\n\u003ch3\u003e10. All Roads of Health Lead to Immune Modulation and Gut Repair\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1.5 Hours\r\n\r\nThis presentation examines the interactions between gastrointestinal biology, immune regulation, and inflammatory signaling.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGut-Immune Interactions\u003c\/li\u003e\r\n \t\u003cli\u003eGastrointestinal Barrier Function\u003c\/li\u003e\r\n \t\u003cli\u003eImmune Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Pathways\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eGastrointestinal Physiology\u003c\/li\u003e\r\n \t\u003cli\u003eGut Microbiome\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Research\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide-Related Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence Evaluation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e11. Liposomal Oral Peptides: Precision Tools for Immune Regulation, Tissue Repair and Longevity Optimization\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Christopher Shade, PhD\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 30 Minutes\r\n\r\n\u003cstrong\u003eCredit Status:\u003c\/strong\u003e Non-CME Presentation\r\n\r\nThis session explores liposomal delivery and related oral peptide formulation concepts.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLiposomal Delivery Systems\u003c\/li\u003e\r\n \t\u003cli\u003eOral Peptide Formulations\u003c\/li\u003e\r\n \t\u003cli\u003eAbsorption\u003c\/li\u003e\r\n \t\u003cli\u003eBioavailability\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Delivery Research\u003c\/li\u003e\r\n \t\u003cli\u003eFormulation Quality\u003c\/li\u003e\r\n \t\u003cli\u003eBiological Stability\u003c\/li\u003e\r\n \t\u003cli\u003eSafety\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThis session is explicitly identified as non-CME in the original curriculum.\r\n\u003ch2\u003eSession VI – Glucose Regulation and Peptide Bioregulators\u003c\/h2\u003e\r\n\u003ch3\u003e12. The Role of Peptides in Glucose and Insulin Regulation – Balancing the Seesaw\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis presentation reviews the relationship between peptide signaling, glucose homeostasis, and insulin-related metabolic pathways.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGlucose Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Health\u003c\/li\u003e\r\n \t\u003cli\u003eIncretin Biology\u003c\/li\u003e\r\n \t\u003cli\u003eGLP-1 Receptor Agonists\u003c\/li\u003e\r\n \t\u003cli\u003eEnergy Balance\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin Resistance\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nSome incretin-based medications have established clinical indications, whereas other peptide-related metabolic compounds remain investigational.\r\n\u003ch3\u003e13. What's New? Peptides and Bioregulators\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis session examines developments in peptide bioregulator research and cellular signaling.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePeptide Bioregulators\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eTissue Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eBiological Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003eRegenerative Research\u003c\/li\u003e\r\n \t\u003cli\u003eLongevity Research\u003c\/li\u003e\r\n \t\u003cli\u003eExperimental Applications\u003c\/li\u003e\r\n \t\u003cli\u003eScientific Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eSafety\u003c\/li\u003e\r\n \t\u003cli\u003eRegulatory Status\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes critical evaluation of evolving therapeutic claims.\r\n\u003ch2\u003eSession VII – Tissue Repair and Regenerative Medicine\u003c\/h2\u003e\r\n\u003ch3\u003e14. Optimize the Body to Heal from Injury: Connective Tissue Organ Repair\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Kathleen O'Neil-Smith, MD, FAARM\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1.5 Hours\r\n\r\nThis presentation reviews tissue repair biology and related regenerative medicine concepts.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eConnective Tissue\u003c\/li\u003e\r\n \t\u003cli\u003eTissue Recovery\u003c\/li\u003e\r\n \t\u003cli\u003eWound Healing Biology\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Repair\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eRegenerative Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eBPC-157 Research\u003c\/li\u003e\r\n \t\u003cli\u003eThymosin Beta-4\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide-Related Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eSafety Considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session explores proposed biological approaches to tissue repair without establishing clinical effectiveness for investigational peptides.\r\n\u003ch2\u003eSession VIII – Cellular Senescence and Longevity\u003c\/h2\u003e\r\n\u003ch3\u003e15. Cellular Senescence: DNA Damage, Telomeres \u0026amp; Zombie Cells\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Kathleen O'Neil-Smith, MD, FAARM\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis presentation examines cellular aging and the biological characteristics of senescent cells.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCellular Senescence\u003c\/li\u003e\r\n \t\u003cli\u003eDNA Damage\u003c\/li\u003e\r\n \t\u003cli\u003eTelomere Biology\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Stress\u003c\/li\u003e\r\n \t\u003cli\u003eSenescence-Associated Secretory Phenotype\u003c\/li\u003e\r\n \t\u003cli\u003eChronic Inflammation\u003c\/li\u003e\r\n \t\u003cli\u003eBiological Aging\u003c\/li\u003e\r\n \t\u003cli\u003eTissue Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eSenolytic Research\u003c\/li\u003e\r\n \t\u003cli\u003eLongevity Science\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session provides an educational overview of emerging research rather than evidence that a particular peptide can reverse human aging.\r\n\u003ch2\u003eSession IX – Hormonal Regulation and Receptor Signaling\u003c\/h2\u003e\r\n\u003ch3\u003e16. Hormone Signaling and Hormone Receptor Modulation\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Marisol Duque, MD\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 2 Hours\r\n\r\nThis presentation examines hormonal signaling pathways and their relationship to metabolic and neuroendocrine function.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHormone Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eHormone Receptors\u003c\/li\u003e\r\n \t\u003cli\u003eEndocrine Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eGrowth Hormone Axis\u003c\/li\u003e\r\n \t\u003cli\u003eGHRH\u003c\/li\u003e\r\n \t\u003cli\u003eGrowth Hormone\u003c\/li\u003e\r\n \t\u003cli\u003eIGF-1\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eReceptor Modulation\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe broader curriculum discusses compounds related to the growth hormone axis, including CJC-1295, ipamorelin, sermorelin, and tesamorelin.\r\n\r\nTheir approved indications, regulatory status, and safety profiles differ and must be evaluated individually.\r\n\u003ch2\u003eSession X – Neuroinflammation and Autoimmunity\u003c\/h2\u003e\r\n\u003ch3\u003e17. Intro to Brain Inflammation and Autoimmune\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Kathleen O'Neil-Smith, MD, FAARM\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThis presentation introduces concepts involving inflammatory pathways, immune regulation, and nervous system biology.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNeuroinflammation\u003c\/li\u003e\r\n \t\u003cli\u003eAutoimmune Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003eBrain Health\u003c\/li\u003e\r\n \t\u003cli\u003eImmune Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eCentral Nervous System\u003c\/li\u003e\r\n \t\u003cli\u003eNeuroimmune Interactions\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Communication\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide-Related Research\u003c\/li\u003e\r\n \t\u003cli\u003eScientific Evidence\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging Therapeutic Concepts\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session examines biological relationships that remain active areas of clinical and preclinical research.\r\n\u003ch2\u003eSession XI – Clinical Cases\u003c\/h2\u003e\r\n\u003ch3\u003e18. Patient Case Panel\u003c\/h3\u003e\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Led by James LaValle, RPh, CCN, MT, DHM, DHPh\r\n\r\n\u003cstrong\u003eDuration:\u003c\/strong\u003e 1 Hour\r\n\r\nThe concluding session integrates important themes from the Module I curriculum through patient-centered discussions.\r\n\r\nRelevant areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eClinical History\u003c\/li\u003e\r\n \t\u003cli\u003eLaboratory Findings\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Health\u003c\/li\u003e\r\n \t\u003cli\u003eBody Composition\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Factors\u003c\/li\u003e\r\n \t\u003cli\u003eRisk Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eRegulatory Status\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Decision-Making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMajor Peptide Categories Covered\u003c\/h2\u003e\r\n\u003ch3\u003eRegenerative and Reparative Peptides\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBPC-157\u003c\/li\u003e\r\n \t\u003cli\u003eThymosin Beta-4\u003c\/li\u003e\r\n \t\u003cli\u003eKPV\u003c\/li\u003e\r\n \t\u003cli\u003eRGN-259\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese compounds are discussed in relation to tissue biology, inflammation, regeneration, and repair research.\r\n\u003ch3\u003eNeurocognitive and CNS-Related Peptides\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eVIP\u003c\/li\u003e\r\n \t\u003cli\u003eSelank\u003c\/li\u003e\r\n \t\u003cli\u003ePE-22-28\u003c\/li\u003e\r\n \t\u003cli\u003ePT-141\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese compounds appear within the broader educational framework. Their proposed neurocognitive applications should not be interpreted as established clinical indications.\r\n\u003ch3\u003eGrowth Hormone Axis and Recovery\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCJC-1295\u003c\/li\u003e\r\n \t\u003cli\u003eIpamorelin\u003c\/li\u003e\r\n \t\u003cli\u003eSermorelin\u003c\/li\u003e\r\n \t\u003cli\u003eTesamorelin\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe curriculum explores pathways associated with growth hormone signaling, endocrine regulation, and related physiological processes.\r\n\u003ch3\u003eMetabolic and Energy-Related Compounds\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMOTS-c\u003c\/li\u003e\r\n \t\u003cli\u003eGhrelin-Related Compounds\u003c\/li\u003e\r\n \t\u003cli\u003eMacimorelin\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese subjects are discussed in relation to metabolism and endocrine signaling.\r\n\u003ch3\u003eGut and Barrier Function\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLarazotide\u003c\/li\u003e\r\n \t\u003cli\u003eKPV\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus includes gastrointestinal barrier biology and immune regulation.\r\n\u003ch3\u003eMetabolic Regulation\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGLP-1 Receptor Agonists\u003c\/li\u003e\r\n \t\u003cli\u003eTirzepatide and Related Incretin Therapies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe course distinguishes established medications from investigational compounds.\r\n\u003ch3\u003eImmune Modulation\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eThymosin Alpha-1\u003c\/li\u003e\r\n \t\u003cli\u003eKPV\u003c\/li\u003e\r\n \t\u003cli\u003eVIP\u003c\/li\u003e\r\n \t\u003cli\u003eRelated Adjunctive Compounds\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eMitochondrial and Cellular Signaling\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNicotinamide Riboside\u003c\/li\u003e\r\n \t\u003cli\u003eIRW\u003c\/li\u003e\r\n \t\u003cli\u003eLRP \/ LQP\u003c\/li\u003e\r\n \t\u003cli\u003eTUDCA\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nSome of these compounds are not peptides and are included as related research subjects.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMajor Topics Covered\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eA4M Peptide Therapy Certification 2026\u003c\/li\u003e\r\n \t\u003cli\u003eModule I Regenerative and Reparative Peptides\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eRegenerative Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eAnti-Aging Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eLongevity Medicine\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Health\u003c\/li\u003e\r\n \t\u003cli\u003eMetaflammation\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eFDA Peptide Regulations\u003c\/li\u003e\r\n \t\u003cli\u003ePharmaceutical Quality Assurance\u003c\/li\u003e\r\n \t\u003cli\u003eSterile Manufacturing\u003c\/li\u003e\r\n \t\u003cli\u003eCompounding Standards\u003c\/li\u003e\r\n \t\u003cli\u003ePersonalized Clinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eNutrition and Lifestyle\u003c\/li\u003e\r\n \t\u003cli\u003eBody Composition\u003c\/li\u003e\r\n \t\u003cli\u003eSARMs\u003c\/li\u003e\r\n \t\u003cli\u003eGlucose Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eGLP-1 Therapies\u003c\/li\u003e\r\n \t\u003cli\u003eImmune Modulation\u003c\/li\u003e\r\n \t\u003cli\u003eGut Barrier Function\u003c\/li\u003e\r\n \t\u003cli\u003eTissue Repair\u003c\/li\u003e\r\n \t\u003cli\u003eConnective Tissue Recovery\u003c\/li\u003e\r\n \t\u003cli\u003ePeptide Bioregulators\u003c\/li\u003e\r\n \t\u003cli\u003eCellular Senescence\u003c\/li\u003e\r\n \t\u003cli\u003eDNA Damage\u003c\/li\u003e\r\n \t\u003cli\u003eTelomere Biology\u003c\/li\u003e\r\n \t\u003cli\u003eHormone Receptor Modulation\u003c\/li\u003e\r\n \t\u003cli\u003eGrowth Hormone Axis\u003c\/li\u003e\r\n \t\u003cli\u003eNeuroinflammation\u003c\/li\u003e\r\n \t\u003cli\u003eAutoimmune Mechanisms\u003c\/li\u003e\r\n \t\u003cli\u003eBPC-157\u003c\/li\u003e\r\n \t\u003cli\u003eThymosin Beta-4\u003c\/li\u003e\r\n \t\u003cli\u003eKPV\u003c\/li\u003e\r\n \t\u003cli\u003eVIP\u003c\/li\u003e\r\n \t\u003cli\u003eSelank\u003c\/li\u003e\r\n \t\u003cli\u003eCJC-1295\u003c\/li\u003e\r\n \t\u003cli\u003eIpamorelin\u003c\/li\u003e\r\n \t\u003cli\u003eSermorelin\u003c\/li\u003e\r\n \t\u003cli\u003eTesamorelin\u003c\/li\u003e\r\n \t\u003cli\u003eMOTS-c\u003c\/li\u003e\r\n \t\u003cli\u003eThymosin Alpha-1\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Peptide Safety\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Medicine\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eRegenerative and Reparative Peptide Research\u003c\/h2\u003e\r\nRegenerative medicine explores biological mechanisms involved in tissue maintenance, cellular signaling, and recovery.\r\n\r\nThe Module I curriculum reviews peptide-related research concerning connective tissue biology, inflammation, and physiological repair mechanisms.\r\n\r\nCompounds such as BPC-157, thymosin beta-4, and KPV are discussed within this broader scientific context.\r\n\r\nHowever, preclinical findings do not automatically establish clinical effectiveness, and the regulatory status of individual compounds must be considered separately.\r\n\u003ch2\u003eMetabolic Health and Body Composition\u003c\/h2\u003e\r\nMetabolic regulation is a central topic of the A4M Module I program.\r\n\r\nThe curriculum examines:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMetabolic Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eGlucose Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin-Related Pathways\u003c\/li\u003e\r\n \t\u003cli\u003eBody Composition\u003c\/li\u003e\r\n \t\u003cli\u003eAdipose Tissue\u003c\/li\u003e\r\n \t\u003cli\u003eSkeletal Muscle\u003c\/li\u003e\r\n \t\u003cli\u003eInflammation\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eLifestyle Factors\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese subjects support a broader understanding of the relationship between metabolism, endocrine function, and clinical assessment.\r\n\u003ch2\u003eImmune Modulation and Gut Biology\u003c\/h2\u003e\r\nThe gastrointestinal and immune systems interact through numerous biological processes.\r\n\r\nThe program explores immune signaling, gastrointestinal barrier function, inflammation, and related peptide research.\r\n\r\nImportant considerations include gut-immune interactions, clinical evidence, and the limitations of proposed treatment approaches.\r\n\u003ch2\u003eCellular Senescence and Longevity\u003c\/h2\u003e\r\nResearch into biological aging examines the relationship between cellular stress, senescence, DNA damage, telomeres, and age-associated disease.\r\n\r\nThe course introduces these concepts and considers their relevance to emerging longevity research.\r\n\r\nThese topics should be interpreted as educational and investigational unless supported by established clinical evidence for a specific intervention.\r\n\u003ch2\u003eHormone Signaling and Endocrine Regulation\u003c\/h2\u003e\r\nPeptide-related pathways contribute to the regulation of several endocrine processes.\r\n\r\nThe curriculum includes discussions involving:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGrowth Hormone Signaling\u003c\/li\u003e\r\n \t\u003cli\u003eGHRH\u003c\/li\u003e\r\n \t\u003cli\u003eIGF-1\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Receptors\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic Regulation\u003c\/li\u003e\r\n \t\u003cli\u003eNeuroendocrine Function\u003c\/li\u003e\r\n \t\u003cli\u003eRelated Peptide Compounds\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus is on understanding biological mechanisms and evaluating the safety and evidence associated with proposed interventions.\r\n\u003ch2\u003ePharmaceutical Quality and Regulatory Compliance\u003c\/h2\u003e\r\nA distinguishing feature of the Module I curriculum is its emphasis on quality assurance and regulatory considerations.\r\n\r\nThe course examines:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFDA Status\u003c\/li\u003e\r\n \t\u003cli\u003eState Regulations\u003c\/li\u003e\r\n \t\u003cli\u003eCompounding\u003c\/li\u003e\r\n \t\u003cli\u003eSterile Manufacturing\u003c\/li\u003e\r\n \t\u003cli\u003eProduct Purity\u003c\/li\u003e\r\n \t\u003cli\u003eProduct Quality\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Safety\u003c\/li\u003e\r\n \t\u003cli\u003eLegal Availability\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evidence\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nHealthcare professionals must evaluate each compound individually rather than assuming that inclusion in a peptide medicine program establishes its safety or approval.\r\n\u003ch2\u003eOfficial Faculty\u003c\/h2\u003e\r\nThe published 2026 Module I faculty includes:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAnthony J. Campbell, PharmD, BCSCP\u003c\/li\u003e\r\n \t\u003cli\u003eTyler Chamberlain, PharmD, FAPC\u003c\/li\u003e\r\n \t\u003cli\u003eGordon Crozier, DO\u003c\/li\u003e\r\n \t\u003cli\u003eMarisol Duque, MD\u003c\/li\u003e\r\n \t\u003cli\u003eJames LaValle, RPh, CCN, MT, DHM, DHPh\u003c\/li\u003e\r\n \t\u003cli\u003eStephanie Mazurek, PharmD\u003c\/li\u003e\r\n \t\u003cli\u003eKathleen O'Neil-Smith, MD, FAARM\u003c\/li\u003e\r\n \t\u003cli\u003eErika Schwartz, MD\u003c\/li\u003e\r\n \t\u003cli\u003eChristopher Shade, PhD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe faculty include physicians, pharmacists, and researchers involved in peptide medicine, pharmaceutical quality, regenerative medicine, metabolism, and clinical education.\r\n\u003ch2\u003eCertification Requirements\u003c\/h2\u003e\r\nThe official A4M Peptide Therapy Certification consists of two modules.\r\n\r\nTo complete the provider's certification pathway, participants must satisfy:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCompletion of Module I\u003c\/li\u003e\r\n \t\u003cli\u003eCompletion of Module II\u003c\/li\u003e\r\n \t\u003cli\u003eActive A4M or International Peptide Society Membership\u003c\/li\u003e\r\n \t\u003cli\u003eApplicable Provider Eligibility and Assessment Requirements\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eModule I alone does not constitute the complete A4M Peptide Therapy Certification.\u003c\/strong\u003e\r\n\u003ch2\u003eContinuing Medical Education\u003c\/h2\u003e\r\nThe original A4M program includes professional education opportunities under the provider's accredited activities.\r\n\r\nThe published Module I on-demand schedule contains approximately 21.5 hours of instruction, including a designated non-CME presentation.\r\n\r\nThe instructional duration should not be treated automatically as the number of accredited CME credits available for a particular purchase.\r\n\u003ch3\u003eImportant CME and Certification Notice\u003c\/h3\u003e\r\nPurchasing separately distributed educational files through MedicalAmboss does not itself provide:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOfficial A4M Certification\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial CME Credits\u003c\/li\u003e\r\n \t\u003cli\u003eA4M Course Registration\u003c\/li\u003e\r\n \t\u003cli\u003eCompletion Certificates\u003c\/li\u003e\r\n \t\u003cli\u003eInternational Peptide Society Membership\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial Examinations\u003c\/li\u003e\r\n \t\u003cli\u003eA4M Learning Platform Access\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher-Hosted Educational Benefits\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWhy This Course Is Relevant\u003c\/h2\u003e\r\nThe \u003cstrong\u003eA4M Peptide Therapy Certification 2026 – Module I: Regenerative \u0026amp; Reparative Peptides\u003c\/strong\u003e provides a structured introduction to contemporary peptide medicine and related scientific research.\r\n\r\nThe program combines peptide biology, metabolic health, tissue repair, immunology, endocrine signaling, pharmaceutical quality, regulatory compliance, and clinical evidence evaluation.\r\n\r\nUnlike courses focusing exclusively on individual peptide compounds, Module I also explores the pharmaceutical, clinical, and legal considerations necessary for responsible assessment of emerging therapies.\r\n\r\nIts multidisciplinary structure is relevant to physicians, pharmacists, and other licensed healthcare professionals seeking an organized educational foundation in peptide science and related research.\r\n\u003ch2\u003eOfficial Program Reference and MedicalAmboss Purchase Scope\u003c\/h2\u003e\r\n\u003cstrong\u003eOfficial A4M 2026 Program:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/www.a4m.com\/peptide-therapy-certification-on-demand-2026.html\" data-rich-text-autolink=\"\"\u003ehttps:\/\/www.a4m.com\/peptide-therapy-certification-on-demand-2026.html\u003c\/a\u003e\r\n\r\n\u003cstrong\u003eOfficial Certification Information:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/learn.a4m.com\/pages\/peptide-therapy-certification\" data-rich-text-autolink=\"\"\u003ehttps:\/\/learn.a4m.com\/pages\/peptide-therapy-certification\u003c\/a\u003e\r\n\r\n\u003cstrong\u003eMedicalAmboss Product:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/medicalamboss.com\/product\/american-academy-of-anti-aging-medicine-peptide-therapy-certification-module-i-2026\/\" data-rich-text-autolink=\"\"\u003ehttps:\/\/medicalamboss.com\/product\/american-academy-of-anti-aging-medicine-peptide-therapy-certification-module-i-2026\/\u003c\/a\u003e\r\n\r\nThese references describe the original educational curriculum, faculty, and certification pathway.\r\n\r\nThey do not independently establish the exact inventory of digital files included in the MedicalAmboss listing.\r\n\r\n\u003cstrong\u003eMedicalAmboss File Scope:\u003c\/strong\u003e This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eShort Description\u003c\/h2\u003e\r\n\u003cstrong\u003eA4M Peptide Therapy Certification 2026 – Module I: Regenerative \u0026amp; Reparative Peptides\u003c\/strong\u003e provides advanced educational training in peptide science, regenerative medicine, metabolic health, tissue repair, immune modulation, hormone signaling, and longevity research.\r\n\r\nThe program includes 18 scheduled sessions covering peptide mechanisms, FDA regulations, pharmaceutical quality assurance, sterile manufacturing, individualized clinical assessment, body composition, glucose and insulin regulation, gut biology, connective tissue recovery, cellular senescence, hormone receptors, and neuroinflammation.\r\n\u003ch2\u003eModule I Course Content\u003c\/h2\u003e\r\n\u003ctable\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003cth\u003eLecture\u003c\/th\u003e\r\n\u003cth\u003eDuration\u003c\/th\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003ePeptides Overview: Controlling Metaflammation, Metabolic Signaling \u0026amp; Clinical Value\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eFDA, Quality Assurance \u0026amp; State-to-State Status\u003c\/td\u003e\r\n\u003ctd\u003e1.5 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eManufacturing of Sterile Product Quality Control — Parts I \u0026amp; II\u003c\/td\u003e\r\n\u003ctd\u003e2 hrs\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003ePersonalized Peptide Protocols\u003c\/td\u003e\r\n\u003ctd\u003e0.5 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eIntegrating Peptides into Clinical Practice\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eGlobal Lifestyle Considerations in Peptide Medicine\u003c\/td\u003e\r\n\u003ctd\u003e1.5 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eSARMs: Science \u0026amp; Controversy\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eBody Composition \u0026amp; Metabolism\u003c\/td\u003e\r\n\u003ctd\u003e2.5 hrs\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eImmune Modulation \u0026amp; Gut Repair\u003c\/td\u003e\r\n\u003ctd\u003e1.5 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eLiposomal Oral Peptides\u003c\/td\u003e\r\n\u003ctd\u003e0.5 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003ePeptides in Glucose \u0026amp; Insulin Regulation\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003ePeptides \u0026amp; Bioregulators\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eConnective Tissue \u0026amp; Organ Repair\u003c\/td\u003e\r\n\u003ctd\u003e1.5 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eCellular Senescence, DNA Damage \u0026amp; Telomeres\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eHormone Signaling \u0026amp; Receptor Modulation\u003c\/td\u003e\r\n\u003ctd\u003e2 hrs\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003eBrain Inflammation \u0026amp; Autoimmune\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003ePatient Case Panel\u003c\/td\u003e\r\n\u003ctd\u003e1 hr\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch2\u003eWho Is This Course For?\u003c\/h2\u003e\r\nDesigned for \u003cstrong\u003elicensed healthcare practitioners\u003c\/strong\u003e interested in \u003cstrong\u003epeptide medicine, anti-aging and longevity medicine, regenerative medicine, functional medicine, metabolic health, hormone optimization, and advanced clinical therapeutics\u003c\/strong\u003e.\r\n\r\n\u003c\/div\u003e\r\n\u003c!-- MAA:RELATED:END --\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":67982437712026,"sku":"MED-AMB10549","price":200.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/macs-0efe51bcb5-51152-51159-ce1e40a10e7dea5ae265.jpg?v=1793146602","url":"https:\/\/ambosscourse.com\/products\/wc-0efe51bcb5f34c14-51152","provider":"Amboss","version":"1.0","type":"link"}